Literature DB >> 16116203

Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo.

Lequn Li1, Rebecca J Greenwald, Esther M Lafuente, Dimitrios Tzachanis, Alla Berezovskaya, Gordon J Freeman, Arlene H Sharpe, Vassiliki A Boussiotis.   

Abstract

The small GTPase Rap1 is transiently activated during TCR ligation and regulates integrin-mediated adhesion. To understand the in vivo functions of Rap1 in regulating T cell immune responses, we generated transgenic (Tg) mice, which express the active GTP-bound mutant Rap1E63 in their T lymphocytes. Although Rap1E63-Tg T cells exhibited increased LFA-1-mediated adhesion, ERK1/2 activation and proliferation of Rap1E63-Tg CD4+ T cells were defective. Rap1E63-Tg T cells primed in vivo and restimulated with specific Ag in vitro, exhibited reduced proliferation and produced reduced levels of IL-2. Rap1E63-Tg mice had severely deficient T cell-dependent B cell responses, as determined by impaired Ig class switching. Rap1E63-Tg mice had an increased fraction of CD4+CD103+ regulatory T cells (Treg), which exhibited enhanced suppressive efficiency as compared with CD4+CD103+ Treg from normal littermate control mice. Depletion of CD103+ Treg significantly restored the impaired responses of Rap1E63-Tg CD4+ T cells. Thus Rap1-GTP is a negative regulator of Th cell responses and one mechanism responsible for this effect involves the increase of CD103+ Treg cell fraction. Our results show that Rap1-GTP promotes the generation of CD103+ Treg and may have significant implications in the development of strategies for in vitro generation of Treg for the purpose of novel immunotherapeutic approaches geared toward tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116203     DOI: 10.4049/jimmunol.175.5.3133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

2.  The αE(CD103)β7 integrin interacts with oral and skin keratinocytes in an E-cadherin-independent manner*.

Authors:  Sarah E Jenkinson; Simon A Whawell; Brenka M Swales; Elaine M Corps; Peter J Kilshaw; Paula M Farthing
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

Review 3.  Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  J Mol Med (Berl)       Date:  2006-09-14       Impact factor: 4.599

Review 4.  Regulatory T cells in pregnancy.

Authors:  Ana Claudia Zenclussen
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

Review 5.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

Review 6.  T cell receptor signalling networks: branched, diversified and bounded.

Authors:  Rebecca J Brownlie; Rose Zamoyska
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

7.  Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms.

Authors:  Lequn Li; Jin sub Kim; Vassiliki A Boussiotis
Journal:  Cell Immunol       Date:  2010-09-22       Impact factor: 4.868

8.  Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression.

Authors:  Muayad Almahariq; Fang C Mei; Hui Wang; Anthony T Cao; Suxia Yao; Lynn Soong; Jiaren Sun; Yingzi Cong; Ju Chen; Xiaodong Cheng
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

Review 9.  Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.

Authors:  Philip J S Stork; Tara J Dillon
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

10.  A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.

Authors:  Bénédicte Cauwe; Lei Tian; Dean Franckaert; Wim Pierson; Kim A Staats; Susan M Schlenner; Adrian Liston
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.